Pathogenesis, Evaluation, and Management of Osteolysis After Total Shoulder Arthroplasty
- Author:
Kyle N. KUNZE
1
;
Laura M. KRIVICICH
;
Christopher BRUSALIS
;
Samuel A. TAYLOR
;
Lawrence V. GULOTTA
;
Joshua S. DINES
;
Michael C. FU
Author Information
- Publication Type:Current Concept
- From:Clinics in Shoulder and Elbow 2022;25(3):244-254
- CountryRepublic of Korea
- Language:English
- Abstract: Radiographic osteolysis after total shoulder arthroplasty (TSA) remains a challenging clinical entity, as it may not initially manifest clinically apparent symptoms but can lead to clinically important complications, such as aseptic loosening. A thorough consideration of medical history and physical examination is essential to rule out other causes of symptomatic TSA—namely, periprosthetic joint infection—as symptoms often progress to vague pain or discomfort due to subtle component loosening. Once confirmed, nonoperative treatment of osteolysis should first be pursued given the potential to avoid surgery-associated risks. If needed, the current surgical options include glenoid polyethylene revision and conversion to reverse shoulder arthroplasty. The current article provides a comprehensive review of the evaluation and management of osteolysis after TSA through an evidence-based discussion of current concepts.
